Dr. Maya Guglin, Director of the VAD program at the University of Kentucky Gill Heart Institute,  is concerned with the quadrupled rate of blood clot incidents in HM11 patients within a two year period.

http://uknow.uky.edu/content/grant-will-fund-study-anticoagulants-and-lvads